BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 9328351)

  • 1. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo.
    Sims NA; White CP; Sunn KL; Thomas GP; Drummond ML; Morrison NA; Eisman JA; Gardiner EM
    Mol Endocrinol; 1997 Oct; 11(11):1695-708. PubMed ID: 9328351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of osteocalcin expression in transgenic mice reveals a species difference in vitamin D regulation of mouse and human osteocalcin genes.
    Clemens TL; Tang H; Maeda S; Kesterson RA; Demayo F; Pike JW; Gundberg CM
    J Bone Miner Res; 1997 Oct; 12(10):1570-6. PubMed ID: 9333117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human osteocalcin promoter directs bone-specific vitamin D-regulatable gene expression in transgenic mice.
    Kesterson RA; Stanley L; DeMayo F; Finegold M; Pike JW
    Mol Endocrinol; 1993 Mar; 7(3):462-7. PubMed ID: 8483481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteocalcin production in primary osteoblast cultures derived from normal and Hyp mice.
    Carpenter TO; Moltz KC; Ellis B; Andreoli M; McCarthy TL; Centrella M; Bryan D; Gundberg CM
    Endocrinology; 1998 Jan; 139(1):35-43. PubMed ID: 9421395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1 alpha,25-dihydroxyvitamin D3 regulates in vivo production of the third component of complement (C3) in bone.
    Jin CH; Shinki T; Hong MH; Sato T; Yamaguchi A; Ikeda T; Yoshiki S; Abe E; Suda T
    Endocrinology; 1992 Nov; 131(5):2468-75. PubMed ID: 1425444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
    Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
    J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the human osteocalcin gene by 24R,25-dihydroxyvitamin D3 occurs through the vitamin D receptor and the vitamin D-responsive element.
    Uchida M; Ozono K; Pike JW
    J Bone Miner Res; 1994 Dec; 9(12):1981-7. PubMed ID: 7872065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression.
    Lian JB; Shalhoub V; Aslam F; Frenkel B; Green J; Hamrah M; Stein GS; Stein JL
    Endocrinology; 1997 May; 138(5):2117-27. PubMed ID: 9112412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancers located within two introns of the vitamin D receptor gene mediate transcriptional autoregulation by 1,25-dihydroxyvitamin D3.
    Zella LA; Kim S; Shevde NK; Pike JW
    Mol Endocrinol; 2006 Jun; 20(6):1231-47. PubMed ID: 16497728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteocalcin abnormalities in Hyp mice reflect altered genetic expression and are not due to altered clearance, affinity for mineral, or ambient phosphorus levels.
    Carpenter TO; Gundberg CM
    Endocrinology; 1996 Dec; 137(12):5213-9. PubMed ID: 8940337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the murine renal vitamin D receptor by 1,25-dihydroxyvitamin D3 and calcium.
    Healy KD; Zella JB; Prahl JM; DeLuca HF
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9733-7. PubMed ID: 12900504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturation state determines the response of osteogenic cells to surface roughness and 1,25-dihydroxyvitamin D3.
    Lohmann CH; Bonewald LF; Sisk MA; Sylvia VL; Cochran DL; Dean DD; Boyan BD; Schwartz Z
    J Bone Miner Res; 2000 Jun; 15(6):1169-80. PubMed ID: 10841186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single up-stream element confers responsiveness to 1,25-dihydroxyvitamin D3 and tumor necrosis factor-alpha in the rat osteocalcin gene.
    Nanes MS; Kuno H; Demay MB; Kurian M; Hendy GN; DeLuca HF; Titus L; Rubin J
    Endocrinology; 1994 Mar; 134(3):1113-20. PubMed ID: 8119149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
    Kaufmann M; Lee SM; Pike JW; Jones G
    Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
    Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
    J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation by 1,25-dihydroxyvitamin D3 of calbindin-D9k and calbindin-D28k gene expression in mouse kidney.
    Li H; Christakos S
    Endocrinology; 1991 Jun; 128(6):2844-52. PubMed ID: 2036965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.
    Yamamoto T; Ozono K; Shima M; Yamaoka K; Okada S
    Exp Cell Res; 1998 Oct; 244(1):71-6. PubMed ID: 9770350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
    Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
    Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses.
    Chen TL; Hauschka PV; Cabrales S; Feldman D
    Endocrinology; 1986 Jan; 118(1):250-9. PubMed ID: 3000737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A; Van Wijnen AJ; Desai RK; Pols HA; Birkenhäger JC; Deluca HF; Denhardt DT; Stein JL; Van Leeuwen JP; Stein GS; Lian JB
    Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.